Analysis of the Prognostic Factors of Extensive Disease Small-Cell Lung Cancer Patients in Tokushima University Hospital

Access this Article

Search this Article

Author(s)

    • Ogino Hirokazu
    • Department of Respiratory Medicine and Rheumatology, Graduate School of Biomedical Sciences, Tokushima University
    • Goto Hisatsugu
    • Department of Respiratory Medicine and Rheumatology, Graduate School of Biomedical Sciences, Tokushima University
    • Arisawa Kokichi
    • Department of Preventive Medicine, Graduate School of Biomedical Sciences, Tokushima University
    • Nishioka Yasuhiko
    • Department of Respiratory Medicine and Rheumatology, Graduate School of Biomedical Sciences, Tokushima University
    • Hanibuchi Masaki
    • Department of Respiratory Medicine and Rheumatology, Graduate School of Biomedical Sciences, Tokushima University
    • Kakiuchi Soji
    • Department of Respiratory Medicine and Rheumatology, Graduate School of Biomedical Sciences, Tokushima University|Department of Oncology, Tokushima Municipal Hospital
    • Saijo Atsuro
    • Department of Respiratory Medicine and Rheumatology, Graduate School of Biomedical Sciences, Tokushima University
    • Tezuka Toshifumi
    • Department of Respiratory Medicine and Rheumatology, Graduate School of Biomedical Sciences, Tokushima University
    • Toyoda Yuko
    • Department of Respiratory Medicine and Rheumatology, Graduate School of Biomedical Sciences, Tokushima University
    • Tobiume Makoto
    • Department of Respiratory Medicine and Rheumatology, Graduate School of Biomedical Sciences, Tokushima University
    • Otsuka Kenji
    • Department of Respiratory Medicine and Rheumatology, Graduate School of Biomedical Sciences, Tokushima University
    • Sakaguchi Satoshi
    • Department of Respiratory Medicine and Rheumatology, Graduate School of Biomedical Sciences, Tokushima University|Department of Respiratory Medicine, Tokushima Prefectural Central Hospital

Abstract

<p>Background: Small-cell lung cancer (SCLC) presents aggressive clinical behavior, and its prognosis is still poor. Previously, performance status (PS), or the existence of brain, bone, or liver metastasis were reported to be unfavorable prognostic factors. Given the recent progress of treatment modalities such as radiotherapy techniques and bone modifying agents, the prognostic factors might be different from previous findings. Therefore, we analyzed the prognostic factors of extensive disease SCLC (ED-SCLC) in recent years. Methods: ED-SCLC patients treated in Tokushima University Hospital between 2010 and 2016 were analyzed. Log-rank test and the Cox proportional hazards regression model was used in univariate and multivariate analysis, respectively. Results: Totally, 79 patients were analyzed. In the univariate analysis, age, PS, interstitial pneumonia (IP), liver metastasis, pleural dissemination, neutrophil counts, hypoalbuminemia, hypercalcemia and several liver and biliary enzymes were identified as poor prognostic factors. In the multivariate analysis, age, PS, IP, and liver and biliary enzymes were identified. Moreover, the PS in patients with liver metastasis was significantly worsened. Conclusions: In this study, we newly demonstrated that IP was a significant poor prognostic factor of ED-SCLC. Although liver metastasis was not extracted in multivariate analysis, it may have an impact on the prognosis of ED-SCLC. J. Med. Invest. 63: 286-293, August, 2016</p>

Journal

  • The Journal of Medical Investigation

    The Journal of Medical Investigation 63(3.4), 286-293, 2016

    Faculty of Medicine Tokushima University

Codes

  • NII Article ID (NAID)
    130005245830
  • NII NACSIS-CAT ID (NCID)
    AA11166929
  • Text Lang
    ENG
  • Article Type
    journal article
  • ISSN
    1343-1420
  • Data Source
    IR  J-STAGE 
Page Top